ליריקה 150 מג ישראל - עברית - Ministry of Health

ליריקה 150 מג

pfizer pfe pharmaceuticals israel ltd - pregabalin - קפסולות - pregabalin 150 mg - pregabalin - pregabalin - lyrica is indicated for the treatment of peripheral and central neuropathic pain in adults. management of fibromyalgia.

ליריקה 200 מג ישראל - עברית - Ministry of Health

ליריקה 200 מג

pfizer pfe pharmaceuticals israel ltd - pregabalin - קפסולות - pregabalin 200 mg - pregabalin - pregabalin - lyrica is indicated for the treatment of peripheral and central neuropathic pain in adults. management of fibromyalgia.

ליריקה 300 מג ישראל - עברית - Ministry of Health

ליריקה 300 מג

pfizer pfe pharmaceuticals israel ltd - pregabalin - קפסולות - pregabalin 300 mg - pregabalin - pregabalin - lyrica is indicated for the treatment of peripheral and central neuropathic pain in adults. management of fibromyalgia.

ליריקה 225 מג ישראל - עברית - Ministry of Health

ליריקה 225 מג

pfizer pfe pharmaceuticals israel ltd - pregabalin - קפסולות - pregabalin 225 mg - pregabalin - pregabalin - lyrica is indicated for the treatment of peripheral and central neuropathic pain in adults.management of fibromyalgia.

וימפט 50 מג ישראל - עברית - Ministry of Health

וימפט 50 מג

neopharm ltd, israel - lacosamide - טבליות מצופות פילם - lacosamide 50 mg - lacosamide - lacosamide - vimpat is indicated as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalization in patients with epilepsy aged 16 years and older.

וימפט 100 מג ישראל - עברית - Ministry of Health

וימפט 100 מג

neopharm ltd, israel - lacosamide - טבליות מצופות פילם - lacosamide 100 mg - lacosamide - lacosamide - vimpat is indicated as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalization in patients with epilepsy aged 16 years and older.

וימפט 150 מג ישראל - עברית - Ministry of Health

וימפט 150 מג

neopharm ltd, israel - lacosamide - טבליות מצופות פילם - lacosamide 150 mg - lacosamide - lacosamide - vimpat is indicated as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalization in patients with epilepsy aged 16 years and older.

וימפט 200 מג ישראל - עברית - Ministry of Health

וימפט 200 מג

neopharm ltd, israel - lacosamide - טבליות מצופות פילם - lacosamide 200 mg - lacosamide - lacosamide - vimpat is indicated as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalization in patients with epilepsy aged 16 years and older.

וימפט 10 מ"ג/מ"ל ישראל - עברית - Ministry of Health

וימפט 10 מ"ג/מ"ל

cts ltd - lacosamide 10 mg / 1 ml - solution for infusion - lacosamide - vimpat is indicated as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalization in patients with epilepsy aged 16 years and older.vimpat solution for infusion is an alternative for patients when oral administration is temporary not feasible.

טרובלט 50 מ"ג ישראל - עברית - Ministry of Health

טרובלט 50 מ"ג

glaxo smith kline (israel) ltd - retigabine 50 mg - film coated tablets - retigabine - trobalt is indicated as adjunctive treatment of drug-resistant partial onset seizures with or without secondary generalization in patients aged 18 -65 years with epilepsy, where other appropriate drug combinations have proved inadequate or have not been tolerated.